Open AccessAllergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
Author(s) -
Dhami Sangeeta,
Nurmatov Ulugbek,
Roberts Graham,
Pfaar Oliver,
Muraro Antonella,
Ansotegui Ignacio J.,
Calderon Moises,
Cingi Cemal,
Demoly Pascal,
Durham Stephen,
Wijk Ronald Gerth,
Halken Susanne,
Hamelmann Eckard,
Hellings Peter,
Jacobsen Lars,
Knol Edward,
Linnemann Desiree Larenas,
Lin Sandra,
Maggina Vivian,
OudeElberink Hanneke,
Pajno Giovanni,
Panwankar Ruby,
Pastorello Elideanna,
Pitsios Constantinos,
Rotiroti Giuseppina,
Timmermans Frans,
Tsilochristou Olympia,
Varga EvaMaria,
Wilkinson Jamie,
Williams Andrew,
Worm Margitta,
Zhang Luo,
Sheikh Aziz
Publication year - 2016
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/s13601-016-0099-6
Subject(s) - medicine , clinical immunology , allergen immunotherapy , protocol (science) , allergy , alternative medicine , clinical trial , intensive care medicine , immunotherapy , allergen , immunology , family medicine , pathology , immune system
Background The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for the Management of Allergic Rhinoconjunctivitis. We seek to critically assess the effectiveness, cost‐effectiveness and safety of AIT in the management of allergic rhinoconjunctivitis. Methods We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre‐defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised. Conclusion The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.